Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.

作者信息

Brunner N G, Namba T, Grob D

出版信息

Neurology. 1972 Jun;22(6):603-10. doi: 10.1212/wnl.22.6.603.

DOI:10.1212/wnl.22.6.603

PMID:4343255

Abstract

摘要

相似文献

Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.

Neurology. 1972 Jun;22(6):603-10. doi: 10.1212/wnl.22.6.603.

The diagnosis and management of myasthenia gravis.

Med J Aust. 1974 Jun 22;1(25):997-1001.

Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.

Ann N Y Acad Sci. 1976;274:577-95. doi: 10.1111/j.1749-6632.1976.tb47717.x.

Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.

Arch Neurol. 1972 Feb;26(2):144-50. doi: 10.1001/archneur.1972.00490080062006.

[Drug therapy in myasthenia gravis].

Tidsskr Nor Laegeforen. 1976 Dec 10;96(34-36):1803-5.

Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.

Neurology. 1971 Oct;21(10):1008-18. doi: 10.1212/wnl.21.10.1008.

Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs.

Trans Am Neurol Assoc. 1978;103:278-81.

High-dose intravenous methylprednisolone in myasthenia gravis.

Arch Neurol. 1985 Dec;42(12):1149-53. doi: 10.1001/archneur.1985.04060110031011.

Theophylline preparations in the treatment of myasthenia gravis.

Trans Am Neurol Assoc. 1971;96:158-61.

Immunosuppressive treatment for juvenile myasthenia gravis.

Eur J Pediatr. 1992 Mar;151(3):215-7. doi: 10.1007/BF01954388.

引用本文的文献

Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.

Orphanet J Rare Dis. 2024 Jan 19;19(1):19. doi: 10.1186/s13023-024-03025-z.

Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

J Transl Med. 2021 Dec 20;19(1):516. doi: 10.1186/s12967-021-03185-7.

Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.

J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537.

Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

J Neurol. 2021 Dec;268(12):4573-4586. doi: 10.1007/s00415-020-10264-0. Epub 2020 Oct 16.

Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis.

Sci Rep. 2020 Aug 11;10(1):13497. doi: 10.1038/s41598-020-70539-4.

Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Gen Thorac Cardiovasc Surg. 2015 Apr;63(4):201-15. doi: 10.1007/s11748-015-0518-y. Epub 2015 Jan 22.

Corticosteroids for myasthenia gravis.

Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD002828. doi: 10.1002/14651858.CD002828.pub2.

Controversies about the treatment of myasthenia gravis.

J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.

Immunopathology of acetylcholine receptors in myasthenia gravis.

Springer Semin Immunopathol. 1982;5(4):389-412. doi: 10.1007/BF01857427.

Benefit from adrenocorticotrophin in myasthenia gravis.

J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):412-5. doi: 10.1136/jnnp.37.4.412.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验